The term white coat hypertension (WCH) was initially introduced in 1984 to describe patients who had hypertension in the office but were normotensive with ambulatory blood pressure monitoring (ABPM). At the time, WCH was simply a phenomenon with nothing known about its possible effect on the development of cardiovascular (CV) disease. Three decades later, it is apparent that hypertension in the...